References
- Ackerman, D. L., R. S. Doster, J. H. Weitkamp, D. M. Aronoff, J. A. Gaddy, and S. D. Townsend. 2017. Human milk oligosaccharides exhibit antimicrobial and antibiofilm properties against Group B Streptococcus. ACS Infectious Diseases 3 (8):595–605. doi: https://doi.org/10.1021/acsinfecdis.7b00064.
- Agoston, K., M. J. Hederos, I. Bajza, and G. Dekany. 2019. Kilogram scale chemical synthesis of 2'-fucosyllactose. Carbohydrate Research 476:71–7. doi: https://doi.org/10.1016/j.carres.2019.03.006.
- Alatorre-Santamaría, S.,. Y. Escamilla-Lozano, F. Guzmán-Rodríguez, M. García-Garibay, G. Rodríguez-Serrano, L. Gómez-Ruiz, and A. Cruz-Guerrero. 2019. Synthesis of fucose-containing disaccharides by glycosylhydrolases from various origins. Applied Biochemistry and Biotechnology 188 (2):369–80. doi: https://doi.org/10.1007/s12010-018-2926-9.
- Alderete, T. L., C. Autran, B. E. Brekke, R. Knight, L. Bode, M. I. Goran, and D. A. Fields. 2015. Associations between human milk oligosaccharides and infant body composition in the first 6 mo of life. The American Journal of Clinical Nutrition 102 (6):1381–8. doi: https://doi.org/10.3945/ajcn.115.115451.
- Alliet, P., G. Puccio, E. Janssens, C. Cajozzo, G. Corsello, B. Berger, P. Sperisen, F. P. Martin, N. Sprenger, and P. Steenhout. 2016. Term infant formula supplemented with human milk oligosaccharides (2’fucosyllactose and Lacto-neotetraose) shifts stoom microbiota and metabolic signatures closer to that of breastfed infants. Journal of Pediatric Gastroenterology & Nutrition 63 (1S):S55. doi: https://doi.org/10.1097/01.mpg.0000489632.17881.57.
- Ammann, R. 2017. Achieving the impossible: Jennewein Biotechnologie is dedicated to the production of human milk oligosaccharides. European Dairy Magazine, May.
- Andreas, N. J., A. Al‐Khalidi, M. Jaiteh, E. Clarke, M. J. Hyde, N. Modi, E. Holmes, B. Kampmann, and K. Mehring Le Doare. 2016. Role of human milk oligosaccharides in Group B Streptococcus colonisation. Clinical & Translational Immunology 5 (8):e99. doi: https://doi.org/10.1038/cti.2016.43.
- Andreas, N. J., B. Kampmann, and K. M. Le-Doare. 2015. Human breast milk: A review on its composition and bioactivity. Early Human Development 91 (11):629–35. doi: https://doi.org/10.1016/j.earlhumdev.2015.08.013.
- Arboe Jennum, C., T. Hauch Fenger, L. M. Bruun, and R. Madsen. 2014. One‐pot glycosylations in the synthesis of human milk Oligosaccharides. European Journal of Organic Chemistry 2014 (15):3232–41. doi: https://doi.org/10.1002/ejoc.201400164.
- Arzamasov, A. A., D. Van Sinderen, and D. A. Rodionov. 2018. Comparative genomics reveals the regulatory complexity of bifidobacterial arabinose and arabino-oligosaccharide utilization. Frontiers in Microbiology 9:776doi: https://doi.org/10.3389/fmicb.2018.00776.
- Austin, S., C. A. De Castro, T. Bénet, Y. Hou, H. Sun, S. K. Thakkar, G. Vinyes-Pares, Y. Zhang, and P. Wang. 2016. Temporal change of the content of 10 oligosaccharides in the milk of Chinese urban mothers. Nutrients 8 (6):346. doi: https://doi.org/10.3390/nu8060346.
- Austin, S., C. A. De Castro, N. Sprenger, A. Binia, M. Affolter, C. L. Garcia-Rodenas, L. Beauport, J. F. Tolsa, and C. J. F. Fumeaux. 2019. Human milk oligosaccharides in the milk of mothers delivering term versus preterm infants. Nutrients 11 (6):1282. doi: https://doi.org/10.3390/nu11061282.
- Autran, C. A., B. P. Kellman, J. H. Kim, E. Asztalos, A. B. Blood, E. C. H. Spence, A. L. Patel, J. Hou, N. E. Lewis, and L. Bode. 2018. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut 67 (6):1064–70. doi: https://doi.org/10.1136/gutjnl-2016-312819.
- Ayechu-Muruzabal, V., A. H. van Stigt, M. Mank, L. E. Willemsen, B. Stahl, J. Garssen, and B. Van't Land. 2018. Diversity of human milk oligosaccharides and effects on early life immune development. Front Pediatr 6:239doi: https://doi.org/10.3389/fped.2018.00239.
- Bai, J., Z. Wu, G. Sugiarto, M. R. Gadi, H. Yu, Y. Li, C. Xiao, A. Ngo, B. Zhao, X. Chen, et al. 2019. Biochemical characterization of Helicobacter pylori α1-3-fucosyltransferase and its application in the synthesis of fucosylated human milk oligosaccharides . Carbohydr. Res 480:1–6. doi: https://doi.org/10.1016/j.carres.2019.05.007.
- Baker, P., J. Smith, L. Salmon, S. Friel, G. Kent, A. Iellamo, J. P. Dadhich, and M. J. Renfrew. 2016. Global trends and patterns of commercial milk-based formula sales: Is an unprecedented infant and young child feeding transition underway?. Public Health Nutrition 19 (14):2540–50. doi: https://doi.org/10.1017/S1368980016001117.
- Ballard, O., and A. L. Morrow. 2013. Human milk composition: Nutrients and bioactive factors. Pediatric Clinics of North America 60 (1):49–74. doi: https://doi.org/10.1016/j.pcl.2012.10.002.
- Bandara, M. D., K. J. Stine, and A. V. Demchenko. 2019a. Chemical synthesis of human milk oligosaccharides: Lacto-N-hexaose Galβ1→3GlcNAcβ1→3 [Galβ1→4GlcNAcβ1→6] Galβ1→4Glc. The Journal of Organic Chemistry 84 (24):16192–8. doi: https://doi.org/10.1021/acs.joc.9b02701.
- Bandara, M. D., K. J. Stine, and A. V. Demchenko. 2019b. The chemical synthesis of human milk oligosaccharides: Lacto-N-tetraose (Galβ1→3GlcNAcβ1→3Galβ1→4Glc)). Carbohydrate Research 486:107824doi: https://doi.org/10.1016/j.carres.2019.107824.
- Bandara, M. D., K. J. Stine, and A. V. Demchenko. 2019c. The chemical synthesis of human milk oligosaccharides: Lacto-N-neotetraose (Galβ1→4GlcNAcβ1→3Galβ1→4Glc)). Carbohydr. Res 483:107743doi: https://doi.org/10.1016/j.carres.2019.107743.
- Bandara, M. D., K. J. Stine, and A. V. Demchenko. 2020. Chemical synthesis of human milk oligosaccharides: Lacto-N-neohexaose (Galβ1 → 4GlcNAcβ1→)2 3,6Galβ1 → 4Glc. Org. Biomol. Chem 18 (9):1747–53. doi: https://doi.org/10.1039/d0ob00172d.
- Barile, D., and R. A. Rastall. 2013. Human milk and related oligosaccharides as prebiotics. Current Opinion in Biotechnology 24 (2):214–9. doi: https://doi.org/10.1016/j.copbio.2013.01.008.
- Baumgärtner, F., J. Conrad, G. A. Sprenger, and C. Albermann. 2014. Synthesis of the human milk oligosaccharide lacto-N-tetraose in metabolically engineered, plasmid-free E. coli . Chembiochem : a European Journal of Chemical Biology 15 (13):1896–900. doi: https://doi.org/10.1002/cbic.201402070.
- Baumgärtner, F., L. Jurzitza, J. Conrad, U. Beifuss, G. A. Sprenger, and C. Albermann. 2015. Synthesis of fucosylated lacto-N-tetraose using whole-cell biotransformation. Bioorganic & Medicinal Chemistry 23 (21):6799–806. doi: https://doi.org/10.1016/j.bmc.2015.10.005.
- Baumgärtner, F., L. Seitz, G. A. Sprenger, and C. Albermann. 2013. Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose. Microbial Cell Factories 12 (1):40doi: https://doi.org/10.1186/1475-2859-12-40.
- Berger, P., J. Plows, R. Jones, T. Alderete, C. Yonemitsu, J. H. Ryoo, L. Bode, and M. Goran. 2019. Human milk oligosaccharides and infant weight in the first 6 months of life (P11-053-19). Current Developments in Nutrition 3 (Supplement_1):nzz048–P11. doi: https://doi.org/10.1093/cdn/nzz048.P11-053-19.
- Bidart, G. N., J. Rodríguez-Díaz, M. Palomino-Schätzlein, V. Monedero, and M. J. Yebra. 2017. Human milk and mucosal lacto- and galacto-N-biose synthesis by transgalactosylation and their prebiotic potential in Lactobacillus species . Appl. Microbiol. Biotechnol 101 (1):205–15. doi: https://doi.org/10.1007/s00253-016-7882-0.
- Bidart, G. N., J. Rodríguez-Díaz, G. Pérez-Martínez, and M. J. Yebra. 2018. The lactose operon from Lactobacillus casei is involved in the transport and metabolism of the human milk oligosaccharide core-2 N-acetyllactosamine. Scientific Reports 8 (1):7152. doi: https://doi.org/10.1038/s41598-018-25660-w.
- Bienenstock, J., R. H. Buck, H. Linke, P. Forsythe, A. M. Stanisz, and W. A. Kunze. 2013. Fucosylated but not sialylated milk oligosaccharides diminish colon motor contractions. PLoS One 8 (10):e76236doi: https://doi.org/10.1371/journal.pone.0076236.
- Black, B. A., V. S. Y. Lee, Y. Y. Zhao, Y. Hu, J. M. Curtis, and M. G. Gänzle. 2012. Structural identification of novel oligosaccharides produced by Lactobacillus bulgaricus and Lactobacillus plantarum. J. Agric. Food Chem 60 (19):4886–94. doi: https://doi.org/10.1021/jf300917m.
- Bode, L. 2012. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22 (9):1147–62. doi: https://doi.org/10.1093/glycob/cws074.
- Bode, L. 2018. Human milk oligosaccharides at the interface of maternal–infant health. Breastfeeding Medicine 13 (S1):S-7–8. doi: https://doi.org/10.1089/bfm.2018.29073.ljb.
- Bode, L., N. Contractor, D. Barile, N. Pohl, A. R. Prudden, G. J. Boons, Y. S. Jin, and S. Jennewein. 2016. Overcoming the limited availability of human milk oligosaccharides: Challenges and opportunities for research and application. Nutrition Reviews 74 (10):635–44. doi: https://doi.org/10.1093/nutrit/nuw025.
- Bode, L., L. Kuhn, H. Y. Kim, L. Hsiao, C. Nissan, M. Sinkala, C. Kankasa, M. Mwiya, D. M. Thea, and G. M. Aldrovandi. 2012. Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding. The American Journal of Clinical Nutrition 96 (4):831–9. doi: https://doi.org/10.3945/ajcn.112.039503.
- Bondue, P., C. Milani, E. Arnould, M. Ventura, G. Daube, G. LaPointe, and V. Delcenserie. 2020. Bifidobacterium mongoliense genome seems particularly adapted to milk oligosaccharide digestion leading to production of antivirulent metabolites. BMC Microbiology 20 (1):12. doi: https://doi.org/10.1186/s12866-020-01804-9.
- Bych, K., M. H. Mikš, T. Johanson, M. J. Hederos, L. K. Vigsnaes, and P. Becker. 2019. Production of HMOs using microbial hosts - from cell engineering to large scale production. Current Opinion in Biotechnology 56:130–7. doi: https://doi.org/10.1016/j.copbio.2018.11.003.
- Cassir, N., S. Benamar, and B. L. Scola. 2016. Clostridium butyricum: From beneficial to a new emerging pathogen. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 22 (1):37–45. doi: https://doi.org/10.1016/j.cmi.2015.10.014.
- Castillo‐Courtade, L., S. Han, S. Lee, F. M. Mian, R. Buck, and P. Forsythe. 2015. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy 70 (9):1091–102. doi: https://doi.org/10.1111/all.12650.
- Champion, E., A. Vogel, S. Bartsch, and G. Dekany. 2019. Mutated fucosidase. U.S. Patent 10,415,021, filed October 23, 2015, and issued September 17, 2019.
- Charbonneau, M. R., D. O'Donnell, L. V. Blanton, S. M. Totten, J. C. C. Davis, M. J. Barratt, J. Cheng, J. Guruge, M. Talcott, J. R. Bain, et al. 2016. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 164 (5):859–71. doi: https://doi.org/10.1016/j.cell.2016.01.024.
- Chen, X. 2015. Human milk oligosaccharides (HMOS): Structure, function, and enzyme-catalyzed synthesis. In Advances in carbohydrate chemistry and biochemistry, ed. D. C. Baker and D. Horton, vol. 72, 1st ed., 113–90. London: Academic Press.
- Cheng, L., M. B. Kiewiet, A. Groeneveld, A. Nauta, and P. de Vos. 2019. Human milk oligosaccharides and its acid hydrolysate LNT2 show immunomodulatory effects via TLRs in a dose and structure-dependent way. Journal of Functional Foods 59:174–84. doi: https://doi.org/10.1016/j.jff.2019.05.023.
- Chen, D., X. Yang, J. Yang, G. Lai, T. Yong, X. Tang, O. Shuai, G. Zhou, Y. Xie, and Q. Wu. 2017. Prebiotic effect of fructooligosaccharides from Morinda officinalis on Alzheimer's Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis . Frontiers in Aging Neuroscience 9:403doi: https://doi.org/10.3389/fnagi.2017.00403.
- Chen, C.,. Y. Zhang, M. Xue, X. W. Liu, Y. Li, X. Chen, P. G. Wang, F. Wang, and H. Cao. 2015. Sequential one-pot multienzyme (OPME) synthesis of lacto-N-neotetraose and its sialyl and fucosyl derivatives. Chemical Communications (Cambridge, England) 51 (36):7689–92. doi: https://doi.org/10.1039/c5cc01330e.
- Chernyak, A., S. Oscarson, and D. Turek. 2000. Synthesis of the Lewis b hexasaccharide and squarate acid–HSA conjugates thereof with various saccharide loadings. Carbohydrate Research 329 (2):309–16. doi: https://doi.org/10.1016/S0008-6215(00)00189-0.
- Chin, Y. W., J. Y. Kim, J. H. Kim, S. M. Jung, and J. H. Seo. 2017. Improved production of 2'-fucosyllactose in engineered Escherichia coli by expressing putative α-1,2-fucosyltransferase, WcfB from Bacteroides fragilis . J. Biotechnol 257:192–8. doi: https://doi.org/10.1016/j.jbiotec.2016.11.033.
- Chin, Y. W., J. Y. Kim, W. H. Lee, and J. H. Seo. 2015. Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase . Journal of Biotechnology 210:107–15. doi: https://doi.org/10.1016/j.jbiotec.2015.06.431.
- Chin, Y. W., N. Seo, J. H. Kim, and J. H. Seo. 2016. Metabolic engineering of Escherichia coli to produce 2'-fucosyllactose via salvage pathway of guanosine 5'-diphosphate (GDP)-l-fucose . Biotechnology and Bioengineering 113 (11):2443–52. doi: https://doi.org/10.1002/bit.26015.
- Choi, Y. H., J. H. Kim, B. S. Park, and B. G. Kim. 2016. Solubilization and iterative saturation mutagenesis of α1,3-fucosyltransferase from Helicobacter pylori to enhance its catalytic efficiency . Biotechnology and Bioengineering 113 (8):1666–75. doi: https://doi.org/10.1002/bit.25944.
- Choi, Y. H., J. H. Kim, J. H. Park, N. Lee, D. H. Kim, K. S. Jang, I. H. Park, and B. G. Kim. 2014. Protein engineering of α2,3/2,6-sialyltransferase to improve the yield and productivity of in vitro sialyllactose synthesis . Glycobiology 24 (2):159–69. doi: https://doi.org/10.1093/glycob/cwt092.
- Choi, Y. H., B. S. Park, J. H. Seo, and B. G. Kim. 2019. Biosynthesis of the human milk oligosaccharide 3-fucosyllactose in metabolically engineered Escherichia coli via the salvage pathway through increasing GTP synthesis and β-galactosidase modification . Biotechnology and Bioengineering 116 (12):3324–32. doi: https://doi.org/10.1002/bit.27160.
- Codee, J. D., A. Ali, H. S. Overkleeft, and G. A. van der Marel. 2011. Novel protecting groups in carbohydrate chemistry. Comptes Rendus Chimie 14 (2/3):178–93. doi: https://doi.org/10.1016/j.crci.2010.05.010.
- Comstock, S. S., M. Li, M. Wang, M. H. Monaco, T. B. Kuhlenschmidt, M. S. Kuhlenschmidt, and S. M. Donovan. 2017. Dietary human milk oligosaccharides but not prebiotic oligosaccharides increase circulating natural killer cell and mesenteric lymph node memory T cell populations in noninfected and rotavirus-infected neonatal piglets. The Journal of Nutrition 147 (6):1041–7. doi: https://doi.org/10.3945/jn.116.243774.
- Coulet, M., P. Phothirath, L. Allais, and B. Schilter. 2014. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL). Regulatory Toxicology and Pharmacology : RTP 68 (1):59–69. doi: https://doi.org/10.1016/j.yrtph.2013.11.005.
- Coulet, M., P. Phothirath, A. Constable, E. Marsden, and B. Schilter. 2013. Pre-clinical safety assessment of the synthetic human milk, nature-identical, oligosaccharide Lacto-N-neotetraose (LNnT). Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 62:528–37. doi: https://doi.org/10.1016/j.fct.2013.09.018.
- Craft, K. M., H. C. Thomas, and S. D. Townsend. 2018. Interrogation of human milk oligosaccharide fucosylation patterns for antimicrobial and antibiofilm trends in group B Streptococcus. ACS Infectious Diseases 4 (12):1755–65. doi: https://doi.org/10.1021/acsinfecdis.8b00234.
- Craft, K. M., and S. D. Townsend. 2017. Synthesis of lacto-N-tetraose. Carbohydrate Research 440/441:43–50. doi: https://doi.org/10.1016/j.carres.2017.02.001.
- Craft, K. M., and S. D. Townsend. 2019. 1-Amino-2'-fucosyllactose inhibits biofilm formation by Streptococcus agalactiae . The Journal of Antibiotics 72 (6):507–12. doi: https://doi.org/10.1038/s41429-019-0151-6.
- Cristofalo, E. A., R. J. Schanler, C. L. Blanco, S. Sullivan, R. Trawoeger, U. Kiechl-Kohlendorfer, G. Dudell, D. J. Rechtman, M. L. Lee, A. Lucas, et al. 2013. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. The Journal of Pediatrics 163 (6):1592–5. doi: https://doi.org/10.1016/j.jpeds.2013.07.011.
- De Leoz, M. L. A., K. M. Kalanetra, N. A. Bokulich, J. S. Strum, M. A. Underwood, J. B. German, D. A. Mills, and C. B. Lebrilla. 2015. Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: A proof-of-concept study. Journal of Proteome Research 14 (1):491–502. doi: https://doi.org/10.1021/pr500759e.
- Deng, J., L. Gu, T. Chen, H. Huang, X. Yin, X. Lv, Y. Liu, N. Li, Z. Liu, J. Li, et al. 2019. Engineering the substrate transport and cofactor regeneration systems for enhancing 2'-fucosyllactose synthesis in Bacillus subtilis . ACS Synthetic Biology 8 (10):2418–27. doi: https://doi.org/10.1021/acssynbio.9b00314.
- Ding, X. M., D. D. Li, S. P. Bai, J. P. Wang, Q. F. Zeng, Z. W. Su, Y. Xuan, and K. Y. Zhang. 2018. Effect of dietary xylooligosaccharides on intestinal characteristics, gut microbiota, cecal short-chain fatty acids, and plasma immune parameters of laying hens. Poultry Science 97 (3):874–81. doi: https://doi.org/10.3382/ps/pex372.
- Dong, X., N. Li, Z. Liu, X. Lv, J. Li, G. Du, M. Wang, and L. Liu. 2019. Modular pathway engineering of key precursor supply pathways for lacto-N-neotetraose production in Bacillus subtilis. Biotechnology for Biofuels 12 (1):1–11. doi: https://doi.org/10.1186/s13068-019-1551-3.
- Dotz, V., S. Rudloff, C. Meyer, G. Lochnit, and C. Kunz. 2015. Metabolic fate of neutral human milk oligosaccharides in exclusively breast-fed infants. Molecular Nutrition & Food Research 59 (2):355–64. doi: https://doi.org/10.1002/mnfr.201400160.
- Duska-McEwen, G., A. P. Senft, T. L. Ruetschilling, E. G. Barrett, and R. H. Buck. 2014. Human milk oligosaccharides enhance innate immunity to respiratory syncytial virus and influenza in vitro. Food and Nutrition Sciences 05 (14):1387–98. doi: https://doi.org/10.4236/fns.2014.514151.
- El-Hawiet, A., E. N. Kitova, and J. S. Klassen. 2015. Recognition of human milk oligosaccharides by bacterial exotoxins. Glycobiology 25 (8):845–54. doi: https://doi.org/10.1093/glycob/cwv025.
- Elison, E.,. L. K. Vigsnaes, L. R. Krogsgaard, J. Rasmussen, N. Sørensen, B. McConnell, T. Hennet, M. O. Sommer, and P. Bytzer. 2016. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. The British Journal of Nutrition 116 (8):1356–68. doi: https://doi.org/10.1017/S0007114516003354.
- Elwakiel, M., J. A. Hageman, W. Wang, I. M. Szeto, J. B. Van Goudoever, K. A. Hettinga, and H. A. Schols. 2018. Human milk oligosaccharides in colostrum and mature milk of Chinese mothers: Lewis positive secretor subgroups. Journal of Agricultural and Food Chemistry 66 (27):7036–43. doi: https://doi.org/10.1021/acs.jafc.8b02021.
- Engels, L., and L. Elling. 2014. WbgL: A novel bacterial α1,2-fucosyltransferase for the synthesis of 2'-fucosyllactose. Glycobiology 24 (2):170–8. doi: https://doi.org/10.1093/glycob/cwt096.
- Escamilla-Lozano, Y., F. Guzmán-Rodríguez, S. Alatorre-Santamaría, M. García-Garibay, L. Gómez-Ruiz, G. Rodríguez-Serrano, and A. Cruz-Guerrero. 2019. Synthesis of fucosyl-oligosaccharides using α-L-fucosidase from Lactobacillus rhamnosus GG. Molecules 24 (13):2402. doi: https://doi.org/10.3390/molecules24132402.
- Facinelli, B., E. Marini, G. Magi, L. Zampini, L. Santoro, C. Catassi, C. Monachesi, O. Gabrielli, and G. V. Coppa. 2019. Breast milk oligosaccharides: Effects of 2'-fucosyllactose and 6'-sialyllactose on the adhesion of Escherichia coli and Salmonella fyris to Caco-2 cells. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 32 (17):2950–2. doi: https://doi.org/10.1080/14767058.2018.1450864.
- Fair, R. J., H. S. Hahm, and P. H. Seeberger. 2015. Combination of automated solid-phase and enzymatic oligosaccharide synthesis provides access to α(2,3)-sialylated glycans. Chemical Communications (Cambridge, England) 51 (28):6183–5. doi: https://doi.org/10.1039/c5cc01368b.
- Fang, J. L., T. W. Tsai, C. Y. Liang, J. Y. Li, and C. C. Yu. 2018. Enzymatic synthesis of human milk fucosides α1,2‐Fucosyl para‐Lacto‐N‐Hexaose and its isomeric derivatives. Advanced Synthesis & Catalysis 360 (17):3213–9. doi: https://doi.org/10.1002/adsc.201800518.
- Fanos, V., A. Reali, M. A. Marcialis, and F. Bardanzellu. 2018. What you have to know about human milk oligosaccharides. Journal of Pediatric and Neonatal Individualized Medicine 7 (1):e070137.
- FDA (U.S. Food and Drug Administration). 2016a. Agency Response Letter, GRAS Notice No. 650.
- FDA (U.S. Food and Drug Administration). 2016b. Agency Response Letter, GRAS Notice No. 659.
- FDA (U.S. Food and Drug Administration). 2017. Agency Response Letter, GRAS Notice No. 749.
- Galeotti, F., G. V. Coppa, L. Zampini, F. Maccari, T. Galeazzi, L. Padella, L. Santoro, O. Gabrielli, and N. Volpi. 2012. On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-aminoacridone. Analytical Biochemistry 430 (1):97–104. doi: https://doi.org/10.1016/j.ab.2012.07.027.
- Gallier, S., K. Vocking, J. A. Post, B. Van De Heijning, D. Acton, E. M. Van Der Beek, and T. Van Baalen. 2015. A novel infant milk formula concept: Mimicking the human milk fat globule structure. Colloids and Surfaces. B, Biointerfaces 136:329–39. doi: https://doi.org/10.1016/j.colsurfb.2015.09.024.
- Gangwar, L., S. Sahu, and D. Deepak. 2018. Synthesis of reverse building blocks of milk oligosaccharides. Chemistry & Biology Interface 8 (3):162–76.
- Garrido, D., S. Ruiz-Moyano, D. G. Lemay, D. A. Sela, J. B. German, and D. A. Mills. 2015. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. Scientific Reports 5:15311. doi: https://doi.org/10.1038/srep15311.
- Gnoth, M. J., C. Kunz, E. Kinne-Saffran, and S. Rudloff. 2000. Human milk oligosaccharides are minimally digested in vitro. The Journal of Nutrition 130 (12):3014–20. doi: https://doi.org/10.1093/jn/130.12.3014.
- Goehring, K. C., A. D. Kennedy, P. A. Prieto, and R. H. Buck. 2014. Direct evidence for the presence of human milk oligosaccharides in the circulation of breastfed infants. PLoS One. 9 (7):e101692. doi: https://doi.org/10.1371/journal.pone.0101692.
- Gonia, S., M. Tuepker, T. Heisel, C. Autran, L. Bode, and C. A. Gale. 2015. Human milk oligosaccharides inhibit Candida albicans invasion of human premature intestinal epithelial cells. The Journal of Nutrition 145 (9):1992–8. doi: https://doi.org/10.3945/jn.115.214940.
- Good, M., C. P. Sodhi, Y. Yamaguchi, H. Jia, P. Lu, W. B. Fulton, L. Y. Martin, T. Prindle, D. F. Nino, Q. Zhou, et al. 2016. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. The British Journal of Nutrition 116 (7):1175–87. doi: https://doi.org/10.1017/S0007114516002944.
- Gridneva, Z., A. Rea, W. J. Tie, C. T. Lai, S. Kugananthan, L. C. Ward, K. Murray, P. E. Hartmann, and D. T. Geddes. 2019. Carbohydrates in human milk and body composition of term infants during the first 12 months of lactation. Nutrients 11 (7):1472. doi: https://doi.org/10.3390/nu11071472.
- Guan, N., H. D. Shin, L. Long, P. Azadi, and R. Chen. 2018. TCA cycle-powered synthesis of fucosylated oligosaccharides. Glycobiology 28 (7):468–73. doi: https://doi.org/10.1093/glycob/cwy047.
- Guo, L., X. Chen, L. Xu, M. Xiao, and L. Lu. 2018. Enzymatic synthesis of 6’-sialyllactose, a dominant sialylated human milk oligosaccharide, by a novel exo-α-sialidase from Bacteroides fragilis NCTC9343. Applied and Environmental Microbiology 84 (13):e00071. doi: https://doi.org/10.1128/AEM.00071-18.
- Guo, Y., C. Jers, A. S. Meyer, A. Arnous, H. Li, F. Kirpekar, and J. D. Mikkelsen. 2014. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans. Journal of Biotechnology 170:60–7. doi: https://doi.org/10.1016/j.jbiotec.2013.11.013.
- Guo, Y., C. Jers, A. S. Meyer, H. Li, F. Kirpekar, and J. D. Mikkelsen. 2015. Modulating the regioselectivity of a Pasteurella multocida sialyltransferase for biocatalytic production of 3'- and 6'-sialyllactose. Enzyme and Microbial Technology 78:54–62. doi: https://doi.org/10.1016/j.enzmictec.2015.06.012.
- Gurung, R. B., D. H. Kim, L. Kim, A. W. Lee, Z. Wang, and Y. Gao. 2018. Toxicological evaluation of 6'-sialyllactose (6'-SL) sodium salt. Regulatory Toxicology and Pharmacology 95:182–9. doi: https://doi.org/10.1016/j.yrtph.2018.03.010.
- Guzmán-Rodríguez, F., S. Alatorre-Santamaría, L. Gómez-Ruiz, G. Rodríguez-Serrano, M. García-Garibay, and A. Cruz-Guerrero. 2018a. Synthesis of a fucosylated trisaccharide via transglycosylation by α-L-fucosidase from Thermotoga maritima. Applied Biochemistry and Biotechnology 186 (3):681–91. doi: https://doi.org/10.1007/s12010-018-2771-x.
- Guzmán-Rodríguez, F., S. Alatorre-Santamaría, L. Gómez-Ruiz, G. Rodríguez-Serrano, M. García-Garibay, and A. Cruz-Guerrero. 2018b. Improvement of the transfucosylation activity of α-L-fucosidase from Thermotoga maritima for the synthesis of fucosylated oligosaccharides in the presence of calcium and sodium. Extremophiles: Life under Extreme Conditions 22 (6):889–94. doi: https://doi.org/10.1007/s00792-018-1045-4.
- GVR (Grand View Research). 2018. Human Milk Oligosaccharides (HMO) Market Size, Share & Trends Analysis Report By Application (Food Supplements, Functional Food & Beverages, Infant Formula), By Region, And Segment Forecasts, 2018 – 2025. Report No. 978-1-68038-608-0. San Francisco, CA: Grand View Research Inc.
- Ha, S. H., C. H. Kwak, J. Y. Park, F. Abekura, Y. C. Lee, J. S. Kim, T. W. Chung, and C. H. Kim. 2020. 3'-sialyllactose targets cell surface protein, SIGLEC-3, and induces megakaryocyte differentiation and apoptosis by lipid raft-dependent endocytosis. Glycoconjugate Journal 37 (2):187–200. doi: https://doi.org/10.1007/s10719-019-09902-1.
- Hanlon, P. R., and B. A. Thorsrud. 2014. A 3-week pre-clinical study of 2′-fucosyllactose in farm piglets. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 74:343–8. doi: https://doi.org/10.1016/j.fct.2014.10.025.
- Hanson, S., M. Best, M. C. Bryan, and C. H. Wong. 2004. Chemoenzymatic synthesis of oligosaccharides and glycoproteins. Trends in Biochemical Sciences 29 (12):656–63. doi: https://doi.org/10.1016/j.tibs.2004.10.004.
- He, Y., N. T. Lawlor, and D. S. Newburg. 2016. Human milk components modulate toll-like Receptor-Mediated Inflammation. Advances in Nutrition (Bethesda, MD) 7 (1):102–11. doi: https://doi.org/10.3945/an.115.010090.
- Hester, S. N., X. Chen, M. Li, M. H. Monaco, S. S. Comstock, T. B. Kuhlenschmidt, M. S. Kuhlenschmidt, and M. S. Donovan. 2013. Human milk oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglets. The British Journal of Nutrition 110 (7):1233–42. doi: https://doi.org/10.1017/S0007114513000391.
- Hirvonen, J., K. Salli, H. Putaala, K. Tiihonen, J. Maukonen, and A. Ouwehand. 2019. Selective utilization of human milk oligosaccharides 2’-FL and 3-FL by probiotic bacteria resulting in different metabolite production by these bacteria (P20-012-19). Current Developments in Nutrition 3 (Supplement_1):nzz040–P20. doi: https://doi.org/10.1093/cdn/nzz040.P20-012-19.
- Hoeflinger, J. L., S. R. Davis, J. Chow, and M. J. Miller. 2015. In vitro impact of human milk oligosaccharides on Enterobacteriaceae growth. Journal of Agricultural and Food Chemistry 63 (12):3295–302. doi: https://doi.org/10.1021/jf505721p.
- Holck, J., D. M. Larsen, M. Michalak, H. Li, L. Kjaerulff, F. Kirpekar, C. H. Gotfredsen, S. Forssten, A. C. Ouwehand, J. D. Mikkelsen, et al. 2014. Enzyme catalysed production of sialylated human milk oligosaccharides and galactooligosaccharides by Trypanosoma cruzi trans-sialidase. New Biotechnology 31 (2):156–65. doi: https://doi.org/10.1016/j.nbt.2013.11.006.
- Hollands, K., C. M. Baron, K. J. Gibson, K. J. Kelly, E. A. Krasley, L. A. Laffend, R. M. Lauchli, L. A. Maggio-Hall, M. J. Nelson, J. C. Prasad, et al. 2019. Engineering two species of yeast as cell factories for 2'-fucosyllactose. Metabolic Engineering 52:232–42. doi: https://doi.org/10.1016/j.ymben.2018.12.005.
- Hsu, C. H., K. C. Chu, Y. S. Lin, J. L. Han, Y. S. Peng, C. T. Ren, C. Y. Wu, and C. H. Wong. 2010. Highly alpha-selective sialyl phosphate donors for efficient preparation of natural sialosides . Chemistry (Weinheim an Der Bergstrasse, Germany) 16 (6):1754–60. doi: https://doi.org/10.1002/chem.200903035.
- Huang, D., K. Yang, J. Liu, Y. Xu, Y. Wang, R. Wang, B. Liu, and L. Feng. 2017. Metabolic engineering of Escherichia coli for the production of 2'-fucosyllactose and 3-fucosyllactose through modular pathway enhancement . Metabolic Engineering 41:23–38. doi: https://doi.org/10.1016/j.ymben.2017.03.001.
- James, K., F. Bottacini, J. I. S. Contreras, M. Vigoureux, M. Egan, M. O. C. Motherway, E. Holmes, and D. van Sinderen. 2019. Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal. Scientific Reports 9 (1):1–20. doi: https://doi.org/10.1038/s41598-019-51901-7.
- James, K., M. O. C. Motherway, F. Bottacini, and D. Van Sinderen. 2016. Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways. Scientific Reports 6 (1):38560–16. doi: https://doi.org/10.1038/srep38560.
- James, K., M. O. C. Motherway, C. Penno, R. L. O'Brien, and D. van Sinderen. 2018. Bifidobacterium breve UCC2003 employs multiple transcriptional regulators to control metabolism of particular human milk oligosaccharides. Applied and Environmental Microbiology 84 (9):e02774–17. doi: https://doi.org/10.1128/AEM.02774-17.
- Jeon, J.,. L. J. Kang, K. M. Lee, C. Cho, E. K. Song, W. Kim, T. J. Park, and S. Yang. 2018. 3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis . Journal of Cellular and Molecular Medicine 22 (1):57–66. doi: https://doi.org/10.1111/jcmm.13292.
- Kang, L. J., E. S. Kwon, K. M. Lee, C. Cho, J. I. Lee, Y. B. Ryu, T. H. Youm, J. Jeon, M. R. Cho, S. Y. Jeong, et al. 2018. 3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis . British Journal of Pharmacology 175 (23):4295–309. doi: https://doi.org/10.1111/bph.14486.
- Kent, G. 2015. Global infant formula: Monitoring and regulating the impacts to protect human health. International Breastfeeding Journal 10 (1):6doi: https://doi.org/10.1186/s13006-014-0020-7.
- Kent, R., G. Fitzgerald, C. Hill, C. Stanton, and R. Ross. 2015. Novel approaches to improve the intrinsic microbiological safety of powdered infant milk formula. Nutrients 7 (2):1217–44. doi: https://doi.org/10.3390/nu7021217.
- Kim, D., R. B. Gurung, W. Seo, A. W. Lee, and J. Woo. 2018. Toxicological evaluation of 3'-sialyllactose sodium salt. Regul. Toxicol. Pharmacol. 94:83–90. doi: https://doi.org/10.1016/j.yrtph.2018.01.020.
- Kim, S., H. Sohn, S. Hong, J. Nam, D. Chang, K. Kim, J. Sun, B. Koo, and Y. Kim. 2017. Environmental evaluation of the productivity and functional fructo-oligosaccharides of yacon cultivated in various regions of Korea. Korean Journal of Crop Science 62 (3):249–58.
- Kobata, A. 2010. Structures and application of oligosaccharides in human milk. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences 86 (7):731–47. doi: https://doi.org/10.2183/pjab.86.731.
- Koromyslova, A., S. Tripathi, V. Morozov, H. Schroten, and G. S. Hansman. 2017. Human norovirus inhibition by a human milk oligosaccharide. Virology 508:81–9. doi: https://doi.org/10.1016/j.virol.2017.04.032.
- Korpela, K.,. A. Salonen, B. Hickman, C. Kunz, N. Sprenger, K. Kukkonen, E. Savilahti, M. Kuitunen, and W. M. de Vos. 2018. Fucosylated oligosaccharides in mother's milk alleviate the effects of caesarean birth on infant gut microbiota. Scientific Reports 8 (1):13757doi: https://doi.org/10.1038/s41598-018-32037-6.
- Kuhn, L., H. Y. Kim, L. Hsiao, C. Nissan, C. Kankasa, M. Mwiya, D. M. Thea, G. M. Aldrovandi, and L. Bode. 2015. Oligosaccharide composition of breast milk influences survival of uninfected children born to HIV-infected mothers in Lusaka, Zambia. The Journal of Nutrition 145 (1):66–72. doi: https://doi.org/10.3945/jn.114.199794.
- Kulinich, A., and L. Liu. 2016. Human milk oligosaccharides: The role in the fine-tuning of innate immune responses. Carbohydrate Research 432:62–70. doi: https://doi.org/10.1016/j.carres.2016.07.009.
- Kunz, C., S. Kuntz, and S. Rudloff. 2014. Bioactivity of human milk oligosaccharides. In Food Oligosaccharides: Production, Analysis and Bioactivity, ed. F. J. Moreno and M. L. Sanz, 1–20. 1st ed. West Sussex: Wiley Blackwell
- Kunz, C., C. Meyer, M. C. Collado, L. Geiger, I. García-Mantrana, B. Bertua-Ríos, C. Martínez-Costa, C. Borsch, and S. Rudloff. 2017. Influence of gestational age, secretor, and Lewis blood group status on the oligosaccharide content of human milk. Journal of Pediatric Gastroenterology and Nutrition 64 (5):789–98. doi: https://doi.org/10.1097/MPG.0000000000001402.
- Lagström, H., S. Rautava, H. Ollila, A. Kaljonen, O. Turta, J. Mäkelä, C. Yonemitsu, J. Gupta, and L. Bode. 2020. Associations between human milk oligosaccharides and growth in infancy and early childhood. The American Journal of Clinical Nutrition 111 (4):769–78. doi: https://doi.org/10.1093/ajcn/nqaa010.
- Laucirica, D. R., V. Triantis, R. Schoemaker, M. K. Estes, and S. Ramani. 2017. Milk oligosaccharides inhibit human rotavirus infectivity in MA104 cells. The Journal of Nutrition 147 (9):1709–14.
- Lawson, M. A. E., I. J. O'Neill, M. Kujawska, S. Gowrinadh Javvadi, A. Wijeyesekera, Z. Flegg, L. Chalklen, and L. J. Hall. 2020. Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. The ISME Journal 14 (2):635–48. doi: https://doi.org/10.1038/s41396-019-0553-2.
- Le Bourgot, C., S. Ferret-Bernard, L. Le Normand, G. Savary, E. Menendez-Aparicio, S. Blat, E. Appert-Bossard, F. Respondek, and I. Le Huërou-Luron. 2014. Maternal short-chain fructooligosaccharide supplementation influences intestinal immune system maturation in piglets. PLoS One. 9 (9):e107508. doi: https://doi.org/10.1371/journal.pone.0107508.
- Lee, W. H., P. Pathanibul, J. Quarterman, J. H. Jo, N. S. Han, M. J. Miller, Y. S. Jin, and J. H. Seo. 2012. Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli. Microbial Cell Factories 11 (1):48doi: https://doi.org/10.1186/1475-2859-11-48.
- Leo, F., S. Asakuma, K. Fukuda, A. Senda, and T. Urashima. 2010. Determination of sialyl and neutral oligosaccharide levels in transition and mature milks of Samoan women, using anthranilic derivatization followed by reverse phase high performance liquid chromatography. Biosci. Biotechnol. Biochem 74 (2):298–303. doi: https://doi.org/10.1271/bbb.90614.
- Lezyk, M., C. Jers, L. Kjaerulff, C. H. Gotfredsen, M. D. Mikkelsen, and J. D. Mikkelsen. 2016. Novel α-L-fucosidases from a soil metagenome for production of fucosylated human milk oligosaccharides. PloS One 11 (1):e0147438doi: https://doi.org/10.1371/journal.pone.0147438.
- Li, M., M. H. Monaco, M. Wang, S. S. Comstock, T. B. Kuhlenschmidt, G. C. Fahey, Jr, M. J. Miller, M. S. Kuhlenschmidt, and S. M. Donovan. 2014. Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota. The ISME Journal 8 (8):1609–20. doi: https://doi.org/10.1038/ismej.2014.10.
- Lin, A. E., C. A. Autran, S. D. Espanola, L. Bode, and V. Nizet. 2014. Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. The Journal of Infectious Diseases 209 (3):389–98. doi: https://doi.org/10.1093/infdis/jit464.
- Lin, A. E., C. A. Autran, A. Szyszka, T. Escajadillo, M. Huang, K. Godula, A. R. Prudden, G. J. Boons, A. L. Lewis, K. S. Doran, et al. 2017. Human milk oligosaccharides inhibit growth of group B Streptococcus. J. Biol. Chem 292 (27):11243–9. doi: https://doi.org/10.1074/jbc.M117.789974.
- Lin, S. H., L. M. Chou, Y. W. Chien, J. S. Chang, and C. I. Lin. 2016. Prebiotic effects of xylooligosaccharides on the improvement of microbiota balance in human subjects. Gastroenterology Research and Practice 2016:5789232doi: https://doi.org/10.1155/2016/5789232.
- Lipták, A., A. Borbás and I. Bajza. 2007 Protecting group manipulations in carbohydrate synthesis. In Introduction to Glycoscience; Synthesis of Carbohydrates, ed. G. J. Boons, Y. C. Lee, A. Suzuki, A. Taniguchi and A. G. J. Voragen, vol 1, 1st ed., 203–59. Elsevier.
- Liu, J. J., S. Kwak, P. Pathanibul, J. W. Lee, S. Yu, E. J. Yun, H. Lim, K. H. Kim, and Y. S. Jin. 2018. Biosynthesis of a functional human milk oligosaccharide, 2'-Fucosyllactose, and l-Fucose Using Engineered Saccharomyces cerevisiae . ACS Synth Biol 7 (11):2529–36. doi: https://doi.org/10.1021/acssynbio.8b00134.
- Liu, F., P. Li, M. Chen, Y. Luo, M. Prabhakar, H. Zheng, Y. He, Q. Qi, H. Long, Y. Zhang, et al. 2017. Fructooligosaccharide (FOS) and galactooligosaccharide (GOS) increase bifidobacterium but reduce butyrate producing bacteria with adverse glycemic metabolism in healthy young population. Scientific Reports 7 (1):11789. doi: https://doi.org/10.1038/s41598-017-10722-2.
- Liu, Z., A. Subbaraj, K. Fraser, H. Jia, W. Chen, L. Day, N. C. Roy, and W. Young. 2020. Human milk and infant formula differentially alters the microbiota composition and functional gene relative abundance in the small and large intestines in weanling rats. European Journal of Nutrition 59 (5):2131–43. doi: https://doi.org/10.1007/s00394-019-02062-w.
- Lönnerdal, B. 2014. Infant formula and infant nutrition: Bioactive proteins of human milk and implications for composition of infant formulas. The American Journal of Clinical Nutrition 99 (3):712S–7S. doi: https://doi.org/10.3945/ajcn.113.071993.
- Love, K. R., and P. H. Seeberger. 2005. Solution syntheses of protected type II Lewis blood group oligosaccharides: Study for automated synthesis. The Journal of Organic Chemistry 70 (8):3168–77. doi: https://doi.org/10.1021/jo047723b.
- Maffei, D., and R. J. Schanler. 2017. Human milk is the feeding strategy to prevent necrotizing enterocolitis!. Seminars in Perinatology 41 (1):36–40. doi: https://doi.org/10.1053/j.semperi.2016.09.016.
- Manosroi, J., N. Khositsuntiwong, and A. Manosroi. 2014. Biological activities of fructooligosaccharide (FOS)-containing Coix lachryma-jobi Linn. extract. Journal of Food Science and Technology 51 (2):341–6. doi: https://doi.org/10.1007/s13197-011-0498-6.
- Mao, X., J. Wang, Y. Hang, Y. Zhang, H. Yu, Z. Li, L. Pan, and Z. Dai. 2019. A human milk oligosaccharide, 2′-fucosyllactose, enhances the immunity in mice fed an infant formula milk diet. International Dairy Journal 98:38–43. doi: https://doi.org/10.1016/j.idairyj.2019.07.001.
- Marriage, B. J., R. H. Buck, K. C. Goehring, J. S. Oliver, and J. A. Williams. 2015. Infants fed a lower calorie formula with 2′ FL show growth and 2′ FL uptake like breast-fed infants. Journal of Pediatric Gastroenterology and Nutrition 61 (6):649–58.
- Martin, C. R., P. R. Ling, and G. L. Blackburn. 2016. Review of infant feeding: Key features of breast milk and infant formula. Nutrients 8 (5):279. doi: https://doi.org/10.3390/nu8050279.
- McArthur, J. B., H. Yu, and X. Chen. 2019. A bacterial β1–3-galactosyltransferase enables multigram-scale synthesis of human milk lacto-N-tetraose (LNT) and its fucosides. ACS Catalysis 9 (12):10721–6. doi: https://doi.org/10.1021/acscatal.9b03990.
- McGuire, M. K., and M. A. McGuire. 2015. Human milk: Mother nature's prototypical probiotic food? Advances in Nutrition (Bethesda, Md.) 6 (1):112–23. doi: https://doi.org/10.3945/an.114.007435.
- McGuire, M., M. A. McGuire, and L. Bode. 2016. Prebiotics and probiotics in human milk: Origins and functions of milk-borne oligosaccharides and bacteria. 1st ed. London: Academic Press.
- Meyer, T. S. M., Â. S. M. Miguel, D. E. R. Fernández, and G. M. D. Ortiz. 2015 Biotechnological production of oligosaccharides. Applications in the food industry. In food production and industry, ed. A. Hafiz and A. Eissa, 25–78. 1st ed. Rijeka: InTech.
- Michalak, M.,. D. M. Larsen, C. Jers, J. R. Almeida, M. Willer, H. Li, F. Kirpekar, L. Kjaerulff, C. H. Gotfredsen, R. T. Nordvang, et al. 2014. Biocatalytic production of 3′-sialyllactose by use of a modified sialidase with superior trans-sialidase activity. Process Biochemistry 49 (2):265–70. doi: https://doi.org/10.1016/j.procbio.2013.10.023.
- Miliku, K., B. Robertson, A. K. Sharma, P. Subbarao, A. B. Becker, P. J. Mandhane, S. E. Turvey, D. L. Lefebvre, M. R. Sears, L. Bode, CHILD Study Investigators, et al. 2018. Human milk oligosaccharide profiles and food sensitization among infants in the CHILD Study. Allergy 73 (10):2070–3. doi: https://doi.org/10.1111/all.13476.
- Monaco, M. H., R. B. Gurung, and S. M. Donovan. 2019. Safety evaluation of 3'-siallylactose sodium salt supplementation on growth and clinical parameters in neonatal piglets . Regulatory Toxicology and Pharmacology : RTP 101:57–64. doi: https://doi.org/10.1016/j.yrtph.2018.11.008.
- Morozov, V., G. Hansman, F. G. Hanisch, H. Schroten, and C. Kunz. 2018. Human milk oligosaccharides as promising antivirals. Molecular Nutrition & Food Research 62 (6):e1700679doi: https://doi.org/10.1002/mnfr.201700679.
- Morrow, A. L., D. S. Newburg, and G. M. Ruiz-Palacios. 2018. Inhibiting inflammation with milk oligosaccharides. U.S. Patent 10,098,903, filed April 30, 2015, and issued October 16, 2018.
- Morrow, A. L., D. S. Newburg, and G. M. Ruiz-Palacios. 2019. Inhibiting inflammation with milk oligosaccharides. U.S. Patent 2019/0099435 A1, filed August 16, 2018, and issued April 4, 2019.
- Morrow, A. L., G. M. Ruiz-Palacios, M. Altaye, X. Jiang, M. L. Guerrero, J. K. Meinzen-Derr, T. Farkas, P. Chaturvedi, K. Pickering, and D. S. Newburg. 2004a. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J. Pediatr 145 (3):297–303. doi: https://doi.org/10.1016/j.jpeds.2004.04.054.
- Morrow, A. L., G. M. Ruiz-Palacios, M. Altaye, X. Jiang, M. L. Guerrero, J. K. Meinzen-Derr, T. Farkas, P. ChaturvediL, K. Pickering, and D. S. Newburg. 2004bHuman milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. In Protecting infants through human milk, ed. L. K. Pickering, A. L. Morrow, G. M. Ruiz-Palacios and R. J. Schanler, vol 554, 1st ed., 443–6. Boston: Springer.
- Morrow, A. L., G. M. Ruiz-Palacios, X. Jiang, and D. S. Newburg. 2005. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. The Journal of Nutrition 135 (5):1304–7. doi: https://doi.org/10.1093/jn/135.5.1304.
- Muschiol, J., and A. S. Meyer. 2019. A chemo-enzymatic approach for the synthesis of human milk oligosaccharide backbone structures. Zeitschrift Fur Naturforschung. C, Journal of Biosciences 74 (3-4):85–9. doi: https://doi.org/10.1515/znc-2018-0149.
- Musilova, S., N. Modrackova, I. Doskocil, R. Svejstil, and V. Rada. 2017. Influence of human milk oligosaccharides on adherence of bifidobacteria and clostridia to cell lines. Acta Microbiologica et Immunologica Hungarica 64 (4):415–22. doi: https://doi.org/10.1556/030.64.2017.029.
- Mussatto, S. I., and I. M. Mancilha. 2007. Non-digestible oligosaccharides: A review. Carbohydrate Polymers 68 (3):587–97. doi: https://doi.org/10.1016/j.carbpol.2006.12.011.
- Newburg, D. S., J. S. Ko, S. Leone, and N. N. Nanthakumar. 2016. Human milk oligosaccharides and synthetic galactosyloligosaccharides contain 3′-, 4-, and 6′-galactosyllactose and attenuate inflammation in human T84, NCM-460, and H4 cells and intestinal tissue ex vivo. The Journal of Nutrition 146 (2):358–67. doi: https://doi.org/10.3945/jn.115.220749.
- Newburg, D. S., G. M. Ruiz-Palacios, M. Altaye, P. Chaturvedi, J. Meinzen-Derr, M. D. L. Guerrero, and A. L. Morrow. 2004. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 14 (3):253–63. doi: https://doi.org/10.1093/glycob/cwh020.
- Newburg, D. S., G. M. Ruiz-Palacios, and A. L. Morrow. 2005. Human milk glycans protect infants against enteric pathogens. Annual Review of Nutrition 25:37–58. doi: https://doi.org/10.1146/annurev.nutr.25.050304.092553.
- Newburg, D. S., A. C. Tanritanir, and S. Chakrabarti. 2016. Lactodifucotetraose, a human milk oligosaccharide, attenuates platelet function and inflammatory cytokine release. Journal of Thrombosis and Thrombolysis 42 (1):46–55. doi: https://doi.org/10.1007/s11239-015-1331-2.
- Neyrinck, A. M., S. Hiel, C. Bouzin, V. G. Campayo, P. D. Cani, L. B. Bindels, and N. M. Delzenne. 2018. Wheat-derived arabinoxylan oligosaccharides with bifidogenic properties abolishes metabolic disorders induced by western diet in mice. Nutrition & Diabetes 8 (1):15doi: https://doi.org/10.1038/s41387-018-0019-z.
- Nobre, C., M. Â. Cerqueira, L. R. Rodrigues, A. A. Vicente, and J. A. Teixeira. 2015 Production and extraction of polysaccharides and oligosaccharides and their use as new food additives. In Industrial biorefineries and white biotechnology, ed. A. Pandey, R. Höfer, C. Larroche, M. Taherzadeh and M. Nampoothiri, 653–79. 1st ed. Waltham: Elsevier.
- Nyffenegger, C., R. T. Nordvang, B. Zeuner, M. Łężyk, E. Difilippo, M. J. Logtenberg, H. A. Schols, A. S. Meyer, and J. D. Mikkelsen. 2015. Backbone structures in human milk oligosaccharides: Trans-glycosylation by metagenomic β-N-acetylhexosaminidases . Appl. Microbiol. Biotechnol 99 (19):7997–8009. doi: https://doi.org/10.1007/s00253-015-6550-0.
- Oh, S. Y., M. S. Park, Y. G. Lee, N. N. Thi, N. I. Baek, and G. E. Ji. 2019. Enzymatic synthesis of β-galactosyl fucose using recombinant bifidobacterial β-galactosidase and its prebiotic effect. Glycoconjugate Journal 36 (3):199–209. doi: https://doi.org/10.1007/s10719-019-09871-5.
- Olivares, M., S. Albrecht, G. De Palma, M. D. Ferrer, G. Castillejo, H. A. Schols, and Y. Sanz. 2015. Human milk composition differs in healthy mothers and mothers with celiac disease. European Journal of Nutrition 54 (1):119–28. doi: https://doi.org/10.1007/s00394-014-0692-1.
- Özcan, E., and D. A. Sela. 2018. Inefficient metabolism of the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose shifts Bifidobacterium longum subsp. infantis physiology. Frontiers in Nutrition 5:46doi: https://doi.org/10.3389/fnut.2018.00046.
- Parschat, K., A. Oehme, J. Leuschner, S. Jennewein, and J. Parkot. 2020. A safety evaluation of mixed human milk oligosaccharides in rats. Food Chem. Toxicol 136:111118doi: https://doi.org/10.1016/j.fct.2020.111118.
- Patel, A. L., T. J. Johnson, J. L. Engstrom, L. F. Fogg, B. J. Jegier, H. R. Bigger, and P. P. Meier. 2013. Impact of early human milk on sepsis and health-care costs in very low birth weight infants. J Perinatol 33 (7):514–9. doi: https://doi.org/10.1038/jp.2013.2.
- Perdijk, O., P. van Baarlen, M. M. Fernandez-Gutierrez, E. Van Den Brink, F. H. Schuren, S. Brugman, H. F. J. Savelkoul, M. Kleerebezem, and R. J. van Neerven. 2019. Sialyllactose and galactooligosaccharides promote epithelial barrier functioning and distinctly modulate microbiota composition and short chain fatty acid production in vitro. Frontiers in Immunology 10 (94):1–14. doi: https://doi.org/10.3389/fimmu.2019.00094.
- Pereira, C. L., and F. E. McDonald. 2012. Synthesis of human milk oligosaccharides: 2'-and 3'-fucosyllactose. Heterocycles 84 (1):637–55. doi: https://doi.org/10.3987/COM-11-S(P)37.
- Pétursson, S. 1997. Protecting groups in carbohydrate chemistry. Journal of Chemical Education 74 (11):1297. doi: https://doi.org/10.1021/ed074p1297.
- Phipps, K. R., N. Baldwin, B. Lynch, J. Flaxmer, A. Šoltésová, B. Gilby, M. H. Mikš, and C. H. Röhrig. 2018. Safety evaluation of a mixture of the human-identical milk oligosaccharides 2'-fucosyllactose and difucosyllactose . Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 120:552–65. doi: https://doi.org/10.1016/j.fct.2018.07.054.
- Phipps, K. R., N. Baldwin, B. Lynch, D. R. Stannard, A. Šoltesová, B. Gilby, M. H. Mikš, and C. H. Röhrig. 2018. Preclinical safety evaluation of the human-identical milk oligosaccharide lacto-N-tetraose. Regulatory Toxicology and Pharmacology : RTP 99:260–73. doi: https://doi.org/10.1016/j.yrtph.2018.09.018.
- Pitt, J., M. Chan, C. Gibson, O. Hasselwander, A. Lim, P. Mukerji, R. Mukherjea, A. Myhre, P. Sarela, P. Tenning, et al. 2019. Safety assessment of the biotechnologically produced human-identical milk oligosaccharide 3-Fucosyllactose (3-FL). Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 134:110818doi: https://doi.org/10.1016/j.fct.2019.110818.
- Plante, O. J., E. R. Palmacci, and P. H. Seeberger. 2001. Automated solid-phase synthesis of oligosaccharides. Science (New York, N.Y.) 291 (5508):1523–7. doi: https://doi.org/10.1126/science.1057324.
- Prudden, A. R., L. Liu, C. J. Capicciotti, M. A. Wolfert, S. Wang, Z. Gao, L. Meng, K. W. Moremen, and G. J. Boons. 2017. Synthesis of asymmetrical multiantennary human milk oligosaccharides. Proceedings of the National Academy of Sciences of the United States of America 114 (27):6954–9. doi: https://doi.org/10.1073/pnas.1701785114.
- Puccio, G., P. Alliet, C. Cajozzo, E. Janssens, G. Corsello, N. Sprenger, S. Wernimont, D. Egli, L. Gosoniu, and P. Steenhout. 2017. Effects of infant formula with human milk oligosaccharides on growth and morbidity: A randomized multicenter trial. Journal of Pediatric Gastroenterology and Nutrition 64 (4):624–31. doi: https://doi.org/10.1097/MPG.0000000000001520.
- Qin, H. M., S. Li, Y. F. Zhang, J. W. Wang, J. Li, S. Song, F. Lu, and Y. Li. 2016. Multienzymatic cascade synthesis of fucosyloligosaccharide via a two-step fermentation strategy in Escherichia coli. Biotechnology Letters 38 (10):1747–52. doi: https://doi.org/10.1007/s10529-016-2151-y.
- Ramani, S., C. J. Stewart, D. R. Laucirica, N. J. Ajami, B. Robertson, C. A. Autran, D. Shinge, S. Rani, S. Anandan, L. Hu, et al. 2018. Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection. Nature Communications 9 (1):1–12. doi: https://doi.org/10.1038/s41467-018-07476-4.
- Rasmussen, S. O., L. Martin, M. V. Østergaard, S. Rudloff, M. Roggenbuck, D. N. Nguyen, P. T. Sangild, and S. B. Bering. 2017. Human milk oligosaccharide effects on intestinal function and inflammation after preterm birth in pigs. The Journal of Nutritional Biochemistry 40:141–54. doi: https://doi.org/10.1016/j.jnutbio.2016.10.011.
- Rollins, N. C., N. Bhandari, N. Hajeebhoy, S. Horton, C. K. Lutter, J. C. Martines, E. G. Piwoz, L. M. Richter, and C. G. Victora. 2016. Why invest, and what it will take to improve breastfeeding practices? The Lancet 387 (10017):491–504. doi: https://doi.org/10.1016/S0140-6736(15)01044-2.
- Ruiz-Palacios, G. M., L. E. Cervantes, P. Ramos, B. Chavez-Munguia, and D. S. Newburg. 2003. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. The Journal of Biological Chemistry 278 (16):14112–20. doi: https://doi.org/10.1074/jbc.M207744200.
- Ruzic, L., J. M. Bolivar, and B. Nidetzky. 2020. Glycosynthase reaction meets the flow: Continuous synthesis of lacto-N-triose II by engineered β-hexosaminidase immobilized on solid support . Biotechnology and Bioengineering 117 (5):1597–602. doi: https://doi.org/10.1002/bit.27293.
- Satoh, T., T. Odamaki, M. Namura, T. Shimizu, K. Iwatsuki, M. Nishimoto, M. Kitaoka, and J. Z. Xiao. 2013. In vitro comparative evaluation of the impact of lacto-N-biose I, a major building block of human milk oligosaccharides, on the fecal microbiota of infants. Anaerobe 19:50–7. doi: https://doi.org/10.1016/j.anaerobe.2012.12.007.
- Saumonneau, A., E. Champion, P. Peltier-Pain, D. Molnar-Gabor, J. Hendrickx, V. Tran, M. Hederos, G. Dekany, and C. Tellier. 2016. Design of an α-L-transfucosidase for the synthesis of fucosylated HMOs. Glycobiology 26 (3):261–9. doi: https://doi.org/10.1093/glycob/cwv099.
- Schmidt, D., and J. Thiem. 2010. Chemical synthesis using enzymatically generated building units for construction of the human milk pentasaccharides sialyllacto-N-tetraose and sialyllacto-N-neotetraose epimer. Beilstein Journal of Organic Chemistry 6:18–7. doi: https://doi.org/10.3762/bjoc.6.18.
- Schmölzer, K., T. Czabany, C. Luley-Goedl, T. Pavkov-Keller, D. Ribitsch, H. Schwab, K. Gruber, H. Weber, and B. Nidetzky. 2015. Complete switch from α-2,3- to α-2,6-regioselectivity in Pasteurella dagmatis β-D-galactoside sialyltransferase by active-site redesign . Chemical Communications (Cambridge, England) 51 (15):3083–6. doi: https://doi.org/10.1039/c4cc09772f.
- Schmölzer, K., M. Weingarten, K. Baldenius, and B. Nidetzky. 2019. Lacto-N-tetraose synthesis by wild-type and glycosynthase variants of the β-N-hexosaminidase from Bifidobacterium bifidum. Organic & Biomolecular Chemistry 17 (23):5661–5. doi: https://doi.org/10.1039/C9OB00424F.
- Seppo, A. E., C. A. Autran, L. Bode, and K. M. Järvinen. 2017. Human milk oligosaccharides and development of cow's milk allergy in infants. The Journal of Allergy and Clinical Immunology 139 (2):708–11. doi: https://doi.org/10.1016/j.jaci.2016.08.031.
- Seydametova, E., J. Yu, J. Shin, Y. Park, C. Kim, H. Kim, S. H. Yu, Y. Park, and D. H. Kweon. 2019. Search for bacterial α1,2-fucosyltransferases for whole-cell biosynthesis of 2'-fucosyllactose in recombinant Escherichia coli . Microbiological Research 222:35–42. doi: https://doi.org/10.1016/j.micres.2019.02.009.
- Sharma, M., S. N. Patel, K. Lata, U. Singh, M. Krishania, R. S. Sangwan, and S. P. Singh. 2016. A novel approach of integrated bioprocessing of cane molasses for production of prebiotic and functional bioproducts. Bioresource Technology 219:311–8. doi: https://doi.org/10.1016/j.biortech.2016.07.131.
- Shi, R., J. Ma, Q. Yan, S. Yang, Z. Fan, and Z. Jiang. 2020. Biochemical characterization of a novel α-L-fucosidase from Pedobacter sp. and its application in synthesis of 3'-fucosyllactose and 2'-fucosyllactose . Applied Microbiology and Biotechnology 104 (13):5813–26. doi: https://doi.org/10.1007/s00253-020-10630-y.
- Sodhi, C. P., P. Wipf, Y. Yamaguchi, W. B. Fulton, M. Kovler, D. F. Niño, Q. Zhou, E. Banfield, A. D. Werts, and M. R. Ladd. 2020. The human milk oligosaccharides 2’-fucosyllactose and 6’-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling. Pediatric Research. Advance Online Publication doi: https://doi.org/10.1038/s41390-020-0852-3..
- Sprenger, N., L. Y. Lee, C. A. De Castro, P. Steenhout, and S. K. Thakkar. 2017. Longitudinal change of selected human milk oligosaccharides and association to infants’ growth, an observatory, single center, longitudinal cohort study. PloS One 12 (2):e0171814. e0171814. doi: https://doi.org/10.1371/journal.pone.0171814.
- Sprenger, N., H. Odenwald, A. K. Kukkonen, M. Kuitunen, E. Savilahti, and C. Kunz. 2017. FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk. European Journal of Nutrition 56 (3):1293–301. doi: https://doi.org/10.1007/s00394-016-1180-6.
- ten Bruggencate, S. J., I. M. Bovee-Oudenhoven, A. L. Feitsma, E. van Hoffen, and M. H. Schoterman. 2014. Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides. Nutrition Reviews 72 (6):377–89. doi: https://doi.org/10.1111/nure.12106.
- Thongaram, T.,. J. L. Hoeflinger, J. Chow, and M. J. Miller. 2017. Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. Journal of Dairy Science 100 (10):7825–33. doi: https://doi.org/10.3168/jds.2017-12753.
- Thurl, S., M. Munzert, G. Boehm, C. Matthews, and B. Stahl. 2017. Systematic review of the concentrations of oligosaccharides in human milk. Nutrition Reviews 75 (11):920–33. doi: https://doi.org/10.1093/nutrit/nux044.
- Tian, S., J. Wang, H. Yu, J. Wang, and W. Zhu. 2018. Effects of galacto-oligosaccharides on growth and gut function of newborn suckling piglets. Journal of Animal Science and Biotechnology 9 (1):75. doi: https://doi.org/10.1186/s40104-018-0290-9.
- Tonon, K. M., M. B. de Morais, A. C. F. V. Abrão, A. Miranda, and T. B. Morais. 2019. Maternal and infant factors associated with human milk oligosaccharides concentrations according to secretor and Lewis phenotypes. Nutrients 11 (6):1358. doi: https://doi.org/10.3390/nu11061358.
- Totten, S. M., A. M. Zivkovic, S. Wu, U. Ngyuen, S. L. Freeman, L. R. Ruhaak, M. K. Darboe, J. B. German, A. M. Prentice, and C. B. Lebrilla. 2012. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. Journal of Proteome Research 11 (12):6124–33. doi: https://doi.org/10.1021/pr300769g.
- Tsai, T. W., J. L. Fang, C. Y. Liang, C. J. Wang, Y. T. Huang, Y. J. Wang, J. Y. Li, and C. C. Yu. 2019. Exploring the synthetic application of Helicobacter pylori α1, 3/4-fucosyltransferase FucTIII toward the syntheses of fucosylated human milk glycans and lewis antigens. ACS Catalysis 9 (12):10712–20. doi: https://doi.org/10.1021/acscatal.9b03752.
- Underwood, M. A., J. C. C. Davis, K. M. Kalanetra, S. Gehlot, S. Patole, D. J. Tancredi, D. A. Mills, C. B. Lebrilla, and K. Simmer. 2017. Digestion of human milk oligosaccharides by Bifidobacterium breve in the premature infant. Journal of Pediatric Gastroenterology and Nutrition 65 (4):449–55. doi: https://doi.org/10.1097/MPG.0000000000001590.
- Underwood, M. A., S. Gaerlan, M. L. A. De Leoz, L. Dimapasoc, K. M. Kalanetra, D. G. Lemay, J. B. German, D. A. Mills, and C. B. Lebrilla. 2015. Human milk oligosaccharides in premature infants: Absorption, excretion, and influence on the intestinal microbiota. Pediatric Research 78 (6):670–7. doi: https://doi.org/10.1038/pr.2015.162.
- Urashima, T., E. Taufik, K. Fukuda, and S. Asakuma. 2013. Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Bioscience, Biotechnology, and Biochemistry 77 (3):455–66. doi: https://doi.org/10.1271/bbb.120810.
- Van Berlo, D., A. E. Wallinga, F. A. van Acker, and D. J. Delsing. 2018. Safety assessment of biotechnologically produced 2'-Fucosyllactose, a novel food additive. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 118:84–93. doi: https://doi.org/10.1016/j.fct.2018.04.049.
- Van den Abbeele, P., C. Duysburgh, E. Vazquez, J. Chow, R. Buck, and M. Marzorati. 2019. 2′-Fucosyllactose alters the composition and activity of gut microbiota from formula-fed infants receiving complementary feeding in a validated intestinal model. Journal of Functional Foods 61:103484. doi: https://doi.org/10.1016/j.jff.2019.103484.
- van Leeuwen, S. S. 2019. Challenges and pitfalls in human milk oligosaccharide analysis. Nutrients 11 (11):2684. doi: https://doi.org/10.3390/nu11112684.
- van Leeuwen, S. S., E. Stoutjesdijk, A. Geert, A. Schaafsma, J. Dijck-Brouwer, F. A. Muskiet, and L. Dijkhuizen. 2018. Regional variations in human milk oligosaccharides in Vietnam suggest FucTx activity besides FucT2 and FucT3. Scientific Reports 8 (1):16790. doi: https://doi.org/10.1038/s41598-018-34882-x.
- Vandenplas, Y., B. Berger, V. P. Carnielli, J. Ksiazyk, H. Lagström, M. Sanchez Luna, N. Migacheva, J. M. Mosselmans, J. C. Picaud, M. Possner, et al. 2018. Human milk oligosaccharides: 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients 10 (9):1161. doi: https://doi.org/10.3390/nu10091161.
- Vázquez, E., A. Barranco, M. Ramírez, A. Gruart, J. M. Delgado-García, E. Martínez-Lara, S. Blanco, M. J. Martín, E. Castanys, R. Buck, et al. 2015. Effects of a human milk oligosaccharide, 2'-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents . The Journal of Nutritional Biochemistry 26 (5):455–65. doi: https://doi.org/10.1016/j.jnutbio.2014.11.016.
- Vazquez, E., A. Santos-Fandila, R. Buck, R. Rueda, and M. Ramirez. 2017. Major human milk oligosaccharides are absorbed into the systemic circulation after oral administration in rats. The British Journal of Nutrition 117 (2):237–47. doi: https://doi.org/10.1017/S0007114516004554.
- Wada, J., Y. Honda, M. Nagae, R. Kato, S. Wakatsuki, T. Katayama, H. Taniguchi, H. Kumagai, M. Kitaoka, and K. Yamamoto. 2008. 1,2-alpha-l-Fucosynthase: a glycosynthase derived from an inverting alpha-glycosidase with an unusual reaction mechanism . FEBS Letters 582 (27):3739–43. doi: https://doi.org/10.1016/j.febslet.2008.09.054.
- Walker, W. A. 2013. Initial intestinal colonization in the human infant and immune homeostasis. Annals of Nutrition and Metabolism 63 (s2):8–15. doi: https://doi.org/10.1159/000354907.
- Wang, J., C. Chen, Z. Yu, Y. He, Q. Yong, and D. S. Newburg. 2017. Relative fermentation of oligosaccharides from human milk and plants by gut microbes. European Food Research and Technology 243 (1):133–46. doi: https://doi.org/10.1007/s00217-016-2730-0.
- Wang, Y., K. Jiang, H. Ma, W. Zeng, P. G. Wang, N. Yao, W. Han, J. Cheng, and W. Wang. 2015. Enzymatic production of HMO mimics by the sialylation of galacto-oligosaccharides. Food Chemistry 181:51–6. doi: https://doi.org/10.1016/j.foodchem.2015.02.064.
- Wang, W.,. L. Li, C. Jin, Y. Niu, S. Li, J. Ma, L. Li, Y. Liu, L. Cai, W. Zhao, et al. 2011. Enzymatic synthesis of a 6-sialyl lactose analogue using a pH-responsive water-soluble polymer support. Bioorganic & Medicinal Chemistry Letters 21 (17):5041–4. doi: https://doi.org/10.1016/j.bmcl.2011.04.076.
- Wang, M., M. Li, S. Wu, C. B. Lebrilla, R. S. Chapkin, I. Ivanov, and S. M. Donovan. 2015. Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. Journal of Pediatric Gastroenterology and Nutrition 60 (6):825–33.
- Wang, C., M. Zhang, H. Guo, J. Yan, F. Liu, J. Chen, Y. Li, and F. Ren. 2019. Human milk oligosaccharides protect against necrotizing enterocolitis by inhibiting intestinal damage via increasing the proliferation of crypt cells. Molecular Nutrition & Food Research 63 (18):1900262. doi: https://doi.org/10.1002/mnfr.201900262.
- Weichert, S., S. Jennewein, E. Hüfner, C. Weiss, J. Borkowski, J. Putze, and H. Schroten. 2013. Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines . Nutrition Research (New York, N.Y.) 33 (10):831–8. doi: https://doi.org/10.1016/j.nutres.2013.07.009.
- Weichert, S., A. Koromyslova, B. K. Singh, S. Hansman, S. Jennewein, H. Schroten, and G. S. Hansman. 2016. Structural basis for norovirus inhibition by human milk oligosaccharides. Journal of Virology 90 (9):4843–8. doi: https://doi.org/10.1128/JVI.03223-15.
- Weinborn, V., Y. Li, I. M. Shah, H. Yu, D. C. Dallas, J. B. German, D. A. Mills, X. Chen, and D. Barile. 2020. Production of functional mimics of human milk oligosaccharides by enzymatic glycosylation of bovine milk oligosaccharides. International Dairy Journal 102:104583. doi: https://doi.org/10.1016/j.idairyj.2019.104583.
- Weiss, G. A., and T. Hennet. 2012. The role of milk sialyllactose in intestinal bacterial colonization. Advances in Nutrition (Bethesda, Md.) 3 (3):483S–8S. doi: https://doi.org/10.3945/an.111.001651.
- Wejryd, E., M. Martí, G. Marchini, A. Werme, B. Jonsson, E. Landberg, and T. Abrahamsson. 2018. Low diversity of human milk oligosaccharides is associated with necrotising enterocolitis in extremely low birth weight infants. Nutrients 10 (10):1556. doi: https://doi.org/10.3390/nu10101556.
- Wickramasinghe, S., A. R. Pacheco, D. G. Lemay, and D. A. Mills. 2015. Bifidobacteria grown on human milk oligosaccharides downregulate the expression of inflammation-related genes in Caco-2 cells. BMC Microbiology 15 (1):172. doi: https://doi.org/10.1186/s12866-015-0508-3.
- Wilbrink, M. H., G. A. ten Kate, P. Sanders, G. J. Gerwig, S. S. van Leeuwen, E. Sallomons, B. Klarenbeek, J. A. Hage, C. A. van Vuure, L. Dijkhuizen, et al. 2015. Enzymatic decoration of prebiotic galacto-oligosaccharides (Vivinal GOS) with sialic acid using Trypanosoma cruzi trans-sialidase and two bovine sialoglycoconjugates as donor substrates. Journal of Agricultural and Food Chemistry 63 (25):5976–84. doi: https://doi.org/10.1021/acs.jafc.5b01505.
- Wu, K. J., Y. H. Chen, E. K. Bae, Y. Song, W. Min, and S. J. Yu. 2020. Human milk oligosaccharide 2′-fucosyllactose reduces neurodegeneration in stroke brain. Translational Stroke Research. Advance Online Publication doi: https://doi.org/10.1007/s12975-019-00774-z..
- Wu, R. Y., B. Li, Y. Koike, P. Määttänen, H. Miyake, M. Cadete, K. C. Johnson-Henry, S. R. Botts, C. Lee, T. R. Abrahamsson, et al. 2019. Human milk oligosaccharides increase mucin expression in experimental necrotizing enterocolitis. Molecular Nutrition & Food Research 63 (3):e1800658doi: https://doi.org/10.1002/mnfr.201800658.
- Xiao, L., P. A. Engen, T. Leusink-Muis, I. van Ark, B. Stahl, S. A. Overbeek, J. Garssen, A. Naqib, S. J. Green, A. Keshavarzian, et al. 2019. The combination of 2′-fucosyllactose with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides that enhance influenza vaccine responses is associated with mucosal immune regulation in mice. The Journal of Nutrition 149 (5):856–69. doi: https://doi.org/10.1093/jn/nxz006.
- Xiao, Z., Y. Guo, Y. Liu, L. Li, Q. Zhang, L. Wen, X. Wang, S. M. Kondengaden, Z. Wu, J. Zhou, et al. 2016. Chemoenzymatic synthesis of a library of human milk oligosaccharides. The Journal of Organic Chemistry 81 (14):5851–65. doi: https://doi.org/10.1021/acs.joc.6b00478.
- Xiao, L., T. Leusink-Muis, N. Kettelarij, I. van Ark, B. Blijenberg, N. A. Hesen, B. Stahl, S. A. Overbeek, J. Garssen, G. Folkerts, et al. 2018. Human milk oligosaccharide 2′-fucosyllactose improves innate and adaptive immunity in an influenza-specific murine vaccination model. Frontiers in Immunology 9:452. doi: https://doi.org/10.3389/fimmu.2018.00452.
- Xiao, L., B. Van't Land, P. A. Engen, A. Naqib, S. J. Green, A. Nato, T. Leusink-Muis, J. Garssen, A. Keshavarzian, B. Stahl, et al. 2018. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Scientific Reports 8 (1):3829doi: https://doi.org/10.1038/s41598-018-22052-y.
- Yan, J., J. Ding, G. Jin, Z. Duan, F. Yang, D. Li, H. Zhou, M. Li, Z. Guo, W. Chai, et al. 2019. Profiling of human milk oligosaccharides for Lewis epitopes and secretor status by electrostatic repulsion hydrophilic interaction chromatography coupled with negative-ion electrospray tandem mass spectrometry. Analytical Chemistry 91 (13):8199–206. doi: https://doi.org/10.1021/acs.analchem.9b00687.
- Yu, Z. T., C. Chen, and D. S. Newburg. 2013. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology 23 (11):1281–92. doi: https://doi.org/10.1093/glycob/cwt065.
- Yu, H., K. Lau, V. Thon, C. A. Autran, E. Jantscher‐Krenn, M. Xue, Y. Li, G. Sugiarto, J. Qu, S. Mu, et al. 2014. Synthetic disialyl hexasaccharides protect neonatal rats from necrotizing enterocolitis. Angewandte Chemie (International ed. in English) 53 (26):6687–91. doi: https://doi.org/10.1002/anie.201403588.
- Yu, S., J. J. Liu, E. J. Yun, S. Kwak, K. H. Kim, and Y. S. Jin. 2018. Production of a human milk oligosaccharide 2'-fucosyllactose by metabolically engineered Saccharomyces cerevisiae . Microbial Cell Factories 17 (1):101doi: https://doi.org/10.1186/s12934-018-0947-2.
- Yu, H., Y. Li, Z. Wu, L. Li, J. Zeng, C. Zhao, Y. Wu, N. Tasnima, J. Wang, H. Liu, et al. 2017. H. pylori α1-3/4-fucosyltransferase (Hp3/4FT)-catalyzed one-pot multienzyme (OPME) synthesis of Lewis antigens and human milk fucosides. Chemical Communications (Cambridge, England) 53 (80):11012–5. doi: https://doi.org/10.1039/c7cc05403c.
- Yu, Z. T., N. N. Nanthakumar, and D. S. Newburg. 2016. The human milk oligosaccharide 2′-fucosyllactose quenches Campylobacter jejuni–induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa. The Journal of Nutrition 146 (10):1980–90. doi: https://doi.org/10.3945/jn.116.230706.
- Yun, E. J., J. J. Liu, J. W. Lee, S. Kwak, S. Yu, K. H. Kim, and Y. S. Jin. 2019. Biosynthetic routes for producing various fucosyl-oligosaccharides. ACS Synthetic Biology 8 (2):415–24. doi: https://doi.org/10.1021/acssynbio.8b00436.
- Yu, J., J. Shin, M. Park, E. Seydametova, S. M. Jung, J. H. Seo, and D. H. Kweon. 2018. Engineering of α-1,3-fucosyltransferases for production of 3-fucosyllactose in Escherichia coli. Metabolic Engineering 48:269–78. doi: https://doi.org/10.1016/j.ymben.2018.05.021.
- Zabel, B., C. C. Yde, P. Roos, J. Marcussen, H. M. Jensen, K. Salli, J. Hirvonen, A. C. Ouwehand, and W. Morovic. 2019. Novel genes and metabolite trends in Bifidobacterium longum subsp. infantis Bi-26 metabolism of human milk oligosaccharide 2'-fucosyllactose. Scientific Reports 9 (1):7983doi: https://doi.org/10.1038/s41598-019-43780-9.
- Zehra, S., I. Khambati, M. Vierhout, M. F. Mian, R. Buck, and P. Forsythe. 2018. Human milk oligosaccharides attenuate Antigen-Antibody Complex Induced Chemokine Release from Human Intestinal Epithelial Cell Lines. Journal of Food Science 83 (2):499–508. doi: https://doi.org/10.1111/1750-3841.14039.
- Zenhom, M., A. Hyder, M. de Vrese, K. J. Heller, T. Roeder, and J. Schrezenmeir. 2011. Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3. The Journal of Nutrition 141 (5):971–7. doi: https://doi.org/10.3945/jn.110.136176.
- Zeuner, B., J. Holck, V. Perna, J. D. Mikkelsen, and A. S. Meyer. 2016. Quantitative enzymatic production of sialylated galactooligosaccharides with an engineered sialidase from Trypanosoma rangeli. Enzyme and Microbial Technology 82:42–50. doi: https://doi.org/10.1016/j.enzmictec.2015.08.010.
- Zeuner, B., J. Muschiol, J. Holck, M. Lezyk, M. R. Gedde, C. Jers, J. D. Mikkelsen, and A. S. Meyer. 2018. Substrate specificity and transfucosylation activity of GH29 α-l-fucosidases for enzymatic production of human milk oligosaccharides. New Biotechnology 41:34–45. doi: https://doi.org/10.1016/j.nbt.2017.12.002.
- Zeuner, B., C. Nyffenegger, J. D. Mikkelsen, and A. S. Meyer. 2016. Thermostable β-galactosidases for the synthesis of human milk oligosaccharides. New Biotechnology 33 (3):355–60. doi: https://doi.org/10.1016/j.nbt.2016.01.003.
- Zeuner, B., A. Riisager, J. D. Mikkelsen, and A. S. Meyer. 2014. Improvement of trans-sialylation versus hydrolysis activity of an engineered sialidase from Trypanosoma rangeli by use of co-solvents. Biotechnology Letters 36 (6):1315–20. doi: https://doi.org/10.1007/s10529-014-1488-3.
- Zeuner, B., M. Vuillemin, J. Holck, J. Muschiol, and A. S. Meyer. 2018. Loop engineering of an α-1, 3/4-L-fucosidase for improved synthesis of human milk oligosaccharides. Enzyme and Microbial Technology 115:37–44. doi: https://doi.org/10.1016/j.enzmictec.2018.04.008.
- Zhang, W., J. Yan, L. Wu, Y. Yu, D. Y. Richard, Y. Zhang, and X. Liang. 2019. In vitro immunomodulatory effects of human milk oligosaccharides on murine macrophage RAW264.7 cells. Carbohydrate Polymers 207:230–8. doi: https://doi.org/10.1016/j.carbpol.2018.11.039.
- Zhao, C., Y. Wu, H. Yu, I. M. Shah, Y. Li, J. Zeng, B. Liu, D. A. Mills, and X. Chen. 2016. The one-pot multienzyme (OPME) synthesis of human blood group H antigens and a Human milk oligosaccharide (HMOS) with highly active Thermosynechococcus elongates α1-2-fucosyltransferase. Chemical Communications (Cambridge, England) 52 (20):3899–902. doi: https://doi.org/10.1039/c5cc10646j.
- Zhu, H., Z. Wu, M. R. Gadi, S. Wang, Y. Guo, G. Edmunds, W. Guan, and J. Fang. 2017. Cation exchange assisted binding-elution strategy for enzymatic synthesis of human milk oligosaccharides (HMOs). Bioorganic & Medicinal Chemistry Letters 27 (18):4285–8. doi: https://doi.org/10.1016/j.bmcl.2017.08.041.